Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,276 | -2,296 | -1,550 | -1,124 | -459 |
| Other Working Capital | 51 | -224 | -242 | -132 | -288 |
| Other Operating Activity | 14,836 | 597 | 402 | 329 | 141 |
| Operating Cash Flow | $-389 | $-1,923 | $-1,390 | $-927 | $-606 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 751 | 525 | N/A |
| Sale Of Investment | N/A | 751 | N/A | N/A | N/A |
| Investing Cash Flow | $N/A | $751 | $751 | $525 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 3 | 3 | -365 | N/A |
| Debt Issued | N/A | 375 | 375 | 375 | 378 |
| Debt Repayment | N/A | N/A | N/A | N/A | -2 |
| Common Stock Issued | 1,667 | 1,500 | 1,500 | 1,500 | N/A |
| Other Financing Activity | -54 | -459 | -459 | -74 | 0 |
| Financing Cash Flow | $1,613 | $1,419 | $1,419 | $1,436 | $376 |
| Beginning Cash Position | 646 | 399 | 399 | 399 | 399 |
| End Cash Position | 1,870 | 646 | 1,179 | 1,433 | 169 |
| Net Cash Flow | $1,224 | $247 | $780 | $1,034 | $-230 |
| Free Cash Flow | |||||
| Operating Cash Flow | -389 | -1,923 | -1,390 | -927 | -606 |
| Free Cash Flow | -389 | -1,923 | -1,390 | -927 | -606 |